ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AC16 | BioTech | Guselkumab - 100mg/ml | 9550 | 41718/1 | TREMFYA | 100mg/ml | 1 | Injectable solution | SC | Abela Frères S.A.L. | Cilag AG | Switzerland | 191,162,296 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AC16 | BioTech | Guselkumab - 100mg/ml | 10625 | 83120/1 | TREMFYA | 100mg/ml | 1 | Injectable solution | SC | Abela Frères S.A.L. | Cilag AG | Switzerland | 191,162,296 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |